0 Комментарии
0 Поделились
194 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Parkinson’s Disorder Drugs Market: Trends, Forecast, and Competitive Landscape 2025 –2032Executive Summary Parkinson’s Disorder Drugs Market: Share, Size & Strategic Insights CAGR Value The global Parkinson’s disorder drugs market size was valued at USD 5.19 billion in 2024 and is expected to reach USD 13.70 billion by 2032, at a CAGR of 12.90% during the forecast period For an excellent outcome of Parkinson’s Disorder...0 Комментарии 0 Поделились 786 Просмотры 0 предпросмотр
-
Blood-Based Biomarker for Parkinson’s Disease Market Worth USD 486.33 Million in 2024, Projected to Reach USD 2,711.91 Million by 2034Polaris Market Research has published insightful research on Blood-Based Biomarker For Parkinson’s Disease Market. The research report offers an in-depth analysis of the market, covering all the major aspects, including market size, market share, growth drivers, and key trends. Besides, a thorough assessment of the annual forecast, strategies, and potential roadmaps has been provided in...0 Комментарии 0 Поделились 83 Просмотры 0 предпросмотр
-
North America Parkinson’s Disease Drug Market Size and Growth ForecastThe Parkinson’s disease drug market is entering a phase of steady transformation as pharmaceutical innovation, demographic shifts, and expanding diagnosis rates reshape the treatment landscape. Parkinson’s disease (PD) is a progressive neurodegenerative disorder that primarily affects movement, creating a long-term need for pharmacological therapy to manage symptoms and improve...0 Комментарии 0 Поделились 261 Просмотры 0 предпросмотр
-
Parkinson's Disease Rehabilitation: A Comprehensive Approach to Improving Daily FunctionUnderstanding Parkinson's Disease Parkinson's disease is a progressive neurological condition that primarily affects movement, but its impact can extend to speech, swallowing, sleep, mood, cognition, and everyday activities. Symptoms can vary considerably between individuals and may change as the condition progresses. Common motor symptoms include tremor, muscle stiffness, slowed movement,...0 Комментарии 0 Поделились 248 Просмотры 0 предпросмотр
-
Parkinson's Disease Treatment Market Analysis: Emerging Therapies and ForecastThe Parkinson'S Disease Treatment Market one is expanding across pharmaceutical, device, rehabilitation, and digital healthcare segments. The progressive nature of Parkinson’s disease creates a long-term need for treatment strategies that can adapt as symptoms and patient requirements change. Medication-based treatment includes several therapeutic classes designed to improve dopaminergic...0 Комментарии 0 Поделились 13 Просмотры 0 предпросмотр
-
Parkinson's Disease Treatment Market: Advancements, Opportunities, and TrendsThe Parkinson's Disease Treatment Market represents a growing area of the healthcare industry, supported by increasing attention toward neurological disorders and the development of new treatment options. As the number of people requiring long-term Parkinson's disease management grows, healthcare systems need therapies and services that can address different stages of the condition. One...0 Комментарии 0 Поделились 44 Просмотры 0 предпросмотр
-
Parkinson’s Disease Market Outlook: 6.3% CAGR Growth Through 2031According to a newly published market research report by 24LifeSciences, global Parkinson's Disease market was valued at USD 5.8 billion in 2024 and is projected to reach USD 8.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 20252031. Parkinson's Disease (PD), clinically recognized as a progressive neurodegenerative disorder, is...0 Комментарии 0 Поделились 220 Просмотры 0 предпросмотр
-
Parkinson’s Disease Therapeutics Market to Reach USD 10.12 Billion by 2032.The Global Parkinson’s disease therapeutics market is accelerating into a new era of scientific possibility and patient-centered innovation, with total valuation projected to climb from USD 5.46 Billion in 2023 to USD 10.12 Billion by 2032-a compound annual growth rate (CAGR) of 7.1% over the forecast period. This sustained expansion is driven by...0 Комментарии 0 Поделились 482 Просмотры 0 предпросмотр
-
Parkinson’s Disease Treatment Market Expands at 6.3% CAGR Through 2031According to a newly published market research report by 24LifeSciences, global Parkinson's Disease market was valued at USD 5.8 billion in 2024 and is projected to reach USD 8.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 20252031. Parkinson's Disease (PD), clinically recognized as...0 Комментарии 0 Поделились 197 Просмотры 0 предпросмотр
-
The Parkinson's Solution: How Parkinson's Disease Devices are Evolving with Advanced TechnologyParkinson's disease (PD) is a progressive neurodegenerative disorder that presents significant challenges for patients and their families. While medication is the mainstay of treatment, its effectiveness often diminishes over time, leading to the emergence of debilitating motor fluctuations and side effects. Parkinson's disease devices , particularly deep brain stimulation (DBS)...0 Комментарии 0 Поделились 78 Просмотры 0 предпросмотр
-
U.S. Blood-Based Biomarker for Parkinson’s Disease Market Projected to Grow at 19.6% CAGR Through 2034Polaris Market Research has published insightful research on U.S. Blood-Based Biomarker For Parkinson’s Disease Market. The research report offers an in-depth analysis of the market, covering all the major aspects, including market size, market share, growth drivers, and key trends. Besides, a thorough assessment of the annual forecast, strategies, and potential roadmaps has been...0 Комментарии 0 Поделились 106 Просмотры 0 предпросмотр
-
Acetylcarnitine Market: Global Outlook & Market DynamicsIntrospective Market Research, a global provider of specialized chemical and pharmaceutical market intelligence, today released its comprehensive analysis of the Global Acetylcarnitine Market. Acetylcarnitine (ALCAR), a crucial derivative of the amino acid carnitine, plays a vital role in mitochondrial energy generation and is highly valued for its antioxidant and neuroprotective properties....0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр
-
Neurological Biomarkers Market Outlook for Biomarker-Based TherapeuticsThe neurological biomarkers market is entering a transformative phase as healthcare and pharmaceutical research increasingly seek faster, more precise, and less invasive ways to understand neurological disorders. Biomarkers are becoming important not only for diagnosis but also for determining disease progression, evaluating treatment response, supporting patient stratification, and improving...0 Комментарии 0 Поделились 336 Просмотры 0 предпросмотр
-
Dementia Care at Home in Noida: Specialized Support for SeniorsCaring for an elderly parent with dementia, Alzheimer's disease, or Parkinson's disease can be challenging for families. Changes in memory, communication, mobility, daily routines, and behavior can mean that seniors need additional support while continuing to live in a familiar environment. Professional home-based care can help families provide structured assistance while respecting the...0 Комментарии 0 Поделились 32 Просмотры 0 предпросмотр
-
Wolff Parkinson White Syndrome Market Advances Through Breakthrough Cardiac Treatment Technologies" According to the latest report published by Data Bridge Market Research, the Wolff Parkinson White Syndrome Market CAGR Value The Wolff Parkinson white syndrome market was valued at USD 1,047.19 million in 2022 and is expected to reach USD 1,466.57 million by 2030, registering a CAGR of 4.30% during the forecast period of 2023-2030. Wolff Parkinson White Syndrome Marketing...0 Комментарии 0 Поделились 195 Просмотры 0 предпросмотр
-
Wolff Parkinson White Syndrome Market Set to Expand with Advances in Cardiac Ablation Therapies" According to the latest report published by Data Bridge Market Research, the Wolff Parkinson White Syndrome Market CAGR Value The Wolff Parkinson white syndrome market was valued at USD 1,047.19 million in 2022 and is expected to reach USD 1,466.57 million by 2030, registering a CAGR of 4.30% during the forecast period of 2023-2030. The persuasive Wolff Parkinson White...0 Комментарии 0 Поделились 110 Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek
Bengali